Recent Data Shows Prophylaxis Is Initiated at a Younger Age for Patients With Severe Hemophilia
Researchers sought to determine whether there were any changes in prophylactic treatment practices among previously untreated patients with hemophilia.
Diagnosis & Disease Information
Problem Joints Are Associated With Worse Quality of Life and Work-Productivity Loss in Adults With Hemophilia
Researchers sought to assess the impact of problem joints in patients with hemophilia.
Haplotype Mismatch Unrelated to Anti-Factor VIII Antibody Binding in Hemophilia A
Researchers sought to determine whether a mismatch between F8 gene haplotypes impacted antibody binding to factor VIII in patients with hemophilia A.
Researchers Address Kinesiophobia in Patients With Hemophilia
Researchers sought to evaluate effects of kinesiophobia among patients with hemophilia.
Emicizumab Is Safe and Effective in Infants With Severe Hemophilia A
Researchers sought to determine whether emicizumab would be effective in treating infants with severe hemophilia A without factor VIII inhibitors.
Factor VIII Concentrate With an Extended Half-Life for Patients With Hemophilia A
Researchers sought to determine whether using factor VIII concentrate with an extended half-life would improve outcomes in patients with hemophilia A.
Efanesoctocog Alfa Prophylaxis in Hemophilia A Improves Physical Function, HRQOL
Post-hoc analysis of XTEND-1 data measured the effects of efanesoctocog alfa prophylaxis on physical function and health-related quality of life in patients with hemophilia A.
Researchers Identity Risk Factors for ICH in Infants and Toddlers With Hemophilia
Researchers investigated potential risk factors associated with intracranial hemorrhage in infants and toddlers with hemophilia.
First Gene Therapy for Hemophilia B Gets FDA Approval
The approval was based on data from the HOPE-B trial that included 54 male participants with severe or moderately severe hemophilia B.
Combination Regimen Highly Effective for Acquired Hemophilia A
Researchers sought to determine whether CyDRi would be a safe and effective treatment for patients with acquired hemophilia A.
- Loading...
Loading...
Next post in Bleeding Disorders
Loading... 
Loading...